- Conditions
- Cholangiocellular Carcinoma) (ICC), Cholangiolar Carcinoma, Intrahepatic Cholangiocarcinoma, Peripheral Cholangiocarcinoma
- Interventions
- DEXAMETHASONE, FLOXURIDINE, GEMCITABINE, Liver resection and placement of hepatic artery infusion pump
- Drug · Procedure
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 8 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2020
- U.S. locations
- 5
- States / cities
- Basking Ridge, New Jersey • Commack, New York • New York, New York + 2 more
Source: ClinicalTrials.gov public record
Updated Sep 10, 2020 · Synced May 18, 2026, 10:37 AM EDT